Analyst
Jefferies
Equibles does not estimate personal net worth.
James Stamos is recorded as Analyst at Jefferies. James Stamos has spoken on 2 investor events across 2 companies, most recently for Vor Biopharma Inc. on June 3, 2026. Those appearances were for Vor Biopharma Inc. (VOR) and Biocryst Pharmaceuticals Inc (BCRX). The companies whose calls James Stamos spoke on are classified in the Healthcare sector.
“It's my pleasure to introduce Jeremy Sokolov, Chief Medical Officer, and Dan Lynn Murray of Chief Commercial Officer of Vore. This is a fireside chat format. Thank you for joining us today.”
“I'm happy to introduce and welcome Charlie Geyer, CEO of Biochrist. This is a fireside chat format. Thank you for joining us today.”
Jefferies
Analyst
Transcript header (unverified)
Drug Manufacturers - Specialty & Generic · Healthcare
